Integrative Approaches to Cancer Immunotherapy-Reference-Cited by-同舟云学术

Integrative Approaches to Cancer Immunotherapy

Published:2019-07 Issue:7 Volume:5 Page:400-410
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Szeto Gregory L.,Finley Stacey D.^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference64 articles.

1. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. 1893;Coley;Clin. Orthop. Relat. Res.,1991

2. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation;Chemnitz;J. Immunol.,2014

3. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms;Parry;Mol. Cell. Biol.,2005

4. T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition;Hui;Science,2017

5. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov.,2018

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current status and research progress of oncolytic virus;Pharmaceutical Science Advances;2024-12

2. Collagen extracellular matrix promotes gastric cancer immune evasion by activating IL4I1-AHR signaling;Translational Oncology;2024-11

3. Melittin-incorporated nanomedicines for enhanced cancer immunotherapy;Journal of Controlled Release;2024-11

4. Multi-omics landscape of Interferon-stimulated gene OASL reveals a potential biomarker in pan-cancer: from prognosis to tumor microenvironment;Frontiers in Immunology;2024-09-02

5. Innate immune cells in tumor microenvironment: A new frontier in cancer immunotherapy;iScience;2024-09